# BioMotiv

BioMotiv is an Asset Manager based in Cleveland, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Cleveland, United States
- **Region:** North America
- **Address:** Cleveland, OH, United States
- **Founded:** 2010
- **Assets under management:** $100M - $500M (Altss estimate)
- **Website:** biomotiv.com
- **LinkedIn:** https://www.linkedin.com/company/biomotiv

## Regulatory record

- **Reports private funds:** No

## About

BioMotiv is the mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million US and UK initiative for advancing medicine centered at University Hospitals in Cleveland. The focus is to accelerate breakthrough discoveries from research institutions into therapeutics for patients through an innovative model that efficiently aligns capital and collaborations. The company leverages an experienced team and advisory board to select, fund, and actively manage and advance a portfolio of programs.

## Sectors

- Therapeutics
- Medical Devices
- Diagnostics
- Life Sciences
- Biotech

## Offices

- Indianapolis, IN, United States

## People

- Baiju R. Shah — CEO
- Michael D. Sosin — Managing Director

## Questions

### How does BioMotiv source proprietary deal flow?

BioMotiv's primary deal flow comes through the Harrington Discovery Institute, an affiliated nonprofit that identifies and funds early-stage academic research with therapeutic potential. This exclusive pipeline gives BioMotiv access to discoveries from leading academic medical centers before they reach the broader venture market.

## Related profiles

- [Peloton Interactive](https://altss.com/profile/peloton-interactive)
- [Ionis Pharmaceuticals](https://altss.com/profile/ionis-pharmaceuticals)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/biomotiv

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology